Psoriatic arthritis: A unified concept twenty years on

Arthritis and Rheumatism

Volumn 42, Issue 6, 1999, Pages 1080-1086

  McGonagle, Dennis ^a   Conaghan, Philip G ^a   Emery, Paul ^a,b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b Department of Rheumatology ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; HLA ANTIGEN CLASS 2; MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RHEUMATOID FACTOR;

ANKYLOSING SPONDYLITIS; BONE SCINTISCANNING; CONTROLLED STUDY; DISEASE ASSOCIATION; ENTHESITIS; HLA SYSTEM; HUMAN; IMMUNOGENICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; REACTIVE ARTHRITIS; REVIEW; RHEUMATOID ARTHRITIS; SPONDYLOARTHROPATHY;

ARTHRITIS, PSORIATIC; HUMANS; TENDINOPATHY; TENDONS;

EID: 0033039293     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199906)42:6<1080::AID-ANR2>3.0.CO;2-7     Document Type: Review

References (62)

1. Wright V. Seronegative polyarthritis: a unified concept. Arthritis Rheum 1978;21:619-33.
2. Wright V, Moll JMH. Psoriatic arthritis. In: Wright V, Moll JMH, editors. Seronegative polyarthritis. Amsterdam: North Holland Publishing; 1976. p. 169-223.
3. Moll JM, Wright V. Psoriatic arthritis. Semin Arthritis Rheum 1973;3:55-78.
4. Helliwell P, Marchesoni A, Peters M, Barker M, Wright V. A re-evaluation of the osteoarticular manifestations of psoriasis. Br J Rheumatol 1991;30:339-45.
5. Torre Alonso JC, Rodriguez Perez A, Arribas Castrillo JM, Ballina Garcia J, Riestra Noriega JL, Lopez Larrea C, et al. Psoriatic arthritis (PA): a clinical, immunological and radiological study of 180 patients. Br J Rheumatol 1991;30:245-50.
6. Scarpa R, Oriente P, Pucino A, Vignone L, Cosentini E, Minerva A, et al. The clinical spectrum of psoriatic spondylitis. Br J Rheumatol 1988;27:133-7.
7. Veale D, Rogers S, FitzGerald O. Classification of clinical subsets in psoriatic arthritis. Br J Rheumatol 1994;33:133-8.
8. Moll JM. The place of psoriatic arthritis in the spondarthritides. Baillieres Clin Rheumatol 1994;8:395-417.
9. McCormack GD, Barth W. Classification and diagnosis of psoriatic arthritis. In: Gerber LH, Espinoza LR, editors. Psoriatic arthritis. New York: Grune and Stratton; 1985. p. 59-82.
10. Barth WF. Psoriatic arthritis sine psoriasis. In: Klippel JH, Dieppe P, editors. Rheumatology. London: Mosby; 1994. p. 34.1-3.
11. Gladman DD, Shuckett R, Russell ML, Thorne JC, Schachter RK. Psoriatic arthritis (PSA) - an analysis of 220 patients. QJM 1987; 62:127-41.
12. Helliwell PS, Wright V. Psoriatic arthritis: clinical features. In: Klippel JH, Dieppe P, editors. Rheumatology. London: Mosby; 1994. p. 31.1-8.
13. Gladmann DD. Psoriatic arthritis. In: Maddison PJ, Isenberg DA, Woo P, Glass DN, editors. Oxford textbook of rheumatology. New York: Oxford University Press; 1998. p. 1071-84.
14. Gladman DD, Anhorn KA, Schachter RK, Mervart H. HLA antigens in psoriatic arthritis. J Rheumatol 1986;13:586-92.
15. Beaulieu AD, Roy R, Mathon G, Morissette J, Latulippe L, Lang JY, et al. Psoriatic arthritis: risk factors for patients with psoriasis - a study based on histocompatibility antigen frequencies. J Rheumatol 1983;10:633-6.
16. Murray C, Mann DL, Gerber LN, Barth W, Perlmann S, Decker JL, et al. Histocompatibility alloantigens in psoriasis and psoriatic arthritis: evidence for the influence of multiple genes in the major histocompatibility complex. J Clin Invest 1980;66:670-5.
17. Armstrong RD, Panayi GS, Welsh KI. Histocompatibility antigens in psoriasis, psoriatic arthropathy, and ankylosing spondylitis. Ann Rheum Dis 1983;42:142-6.
18. Sakkas LI, Loqueman N, Bird H, Vaughan RW, Welsh KI, Panayi GS. HLA class II and T cell receptor gene polymorphisms in psoriatic arthritis and psoriasis. J Rheumatol 1990;17:1487-90.
19. Resnick D, Niwayama G. Psoriatic arthritis. In: Resnick D, editor. Diagnosis of bone and joint disorders. Philadelphia: Saunders; 1995. p. 1075-102.
20. Watt I. Basic differential diagnosis of arthritis. Eut Radiol 1997; 7:344-51.
21. Fournie B, Granel J, Bonnet M, Dromer C, Pages M, Billey T, et al. Incidence of signs indicating psoriatic rheumatism in radiological involvement of fingers and toes. Rev Rhum 1992;59:177-80.
22. 99mtechnetium diphosphonate in psoriatics: correlation with cutaneous activity. Arthritis Rheum 1976;19:607-12.
23. Hahn K, Thiers G, Eibner D. Bone scintigraphy in psoriasis. Nuklearmedizin 1980;19:178-86.
24. Jevtic V, Watt I, Rozman B, Kos-Golja M, Demsar F, Jarh O. Distinctive radiological features of small hand joints in rheumatoid arthritis and seronegative spondyloarthritis demonstrated by contrast-enhanced (Gd-DTPA) magnetic resonance imaging. Skel Radiol 1995;24:351-5.
25. Jevtic V, Rozman B, Kos-Golja M, Watt I. MR imaging in seronegative spondyloarthritis. Radiologe 1986;36:624-31.
26. McGonagle D, Gibbon W, O'Connor P, Green M, Pease C, Emery P. Characteristic magnetic resonance imaging entheseal changes in knee synovitis in spondylarthropathy. Arthritis Rheum 1998;41: 694-700.
27. McGonagle D, Gibbon W, O'Connor P, Green M, Pease C, Ridgway J, et al. An anatomical explanation for good prognosis rheumatoid arthritis. Lancet 1999;353:123-4.
28. Wong WM, Howell WM, Coy SD, Cawley MI, Smith JL. Interleukin-2 is found in the synovium of psoriatic arthritis and spondyloarthritis, not in rheumatoid arthritis. Scand J Rheumatol 1996;25:239-45.
29. Pitzalis C, Cauli A, Pipitone N, Smith C, Barker J, Marchesoni A, et al. Cutaneous lymphocyte antigen-positive T lymphocytes preferentially migrate to the skin but not to the joint in psoriatic arthritis. Arthritis Rheum 1996;39:137-45.
30. Lehtinen A, Taavitsainen M, Leirisalo-Repo M. Sonographic analysis of enthesopathy in the lower extremities of patients with spondylarthropathy. Clin Exp Rheumatol 1994;2:143-8.
31. Hanly JG, Russell ML, Gladman DD. Psoriatic spondyloarthropathy: a long term prospective study. Ann Rheum Dis 1988;47: 386-93.
32. Lambert JR, Wright V. Psoriatic spondylitis: a clinical and radiological description of the spine in psoriatic arthritis. QJM 1977;46: 411-25.
33. Salvarani C, Cantini F, Olivieri I, Macchioni P, Niccoli L, Padula A, et al. Isolated peripheral enthesitis and/or dactylitis: a subset of psoriatic arthritis. J Rheumatol 1997;24:1106-10.
34. Olivieri I, Barozzi L, Favaro L, Pierro A, de Matteis M, Borghi C, et al. Dactylitis in patients with seronegative spondylarthropathy: assessment by ultrasonography and magnetic resonance imaging. Arthritis Rheum 1996;39:1524-8.
35. Kahn MF. Psoriatic arthritis and synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome. Curr Opin Rheumatol 1993;5:428-35.
36. Maugars Y, Berthelot JM, Ducloux JM, Prost A. SAPHO syndrome: a followup study of 19 cases with special emphasis on enthesis involvement. J Rheumatol 1995;22:2135-41.
37. Sonozaki H, Kawashima M, Hongo O, Yaoita H, Ikeno M, Matsuura M, et al. Incidence of arthro-osteitis in patients with pustulosis palmaris et plantaris. Ann Rheum Dis 1981;40:554-7.
38. Sonozaki H, Mitsui H, Miyanaga Y, Okitsu K, Igarashi M, Hayashi Y, et al. Clinical features of 53 cases with pustulotic arthro-osteitis. Ann Rheum Dis 1981;40:547-53.
39. Toussirot E, Dupond JL, Wendung D. Spondylodiscitis in SAPHO syndrome: a series of eight cases. Ann Rheum Dis 1997;56:52-8.
40. Schroder K, Goerdt S, Sieper J, Krasagakis K, Almond-Roesler B, Orfanos CE. Psoriatic onycho-pachydermo-periostitis (POPP). Hautarzt 1997;48:500-3.
41. Goupille P, Vedere V, Roulot B, Brunais J, Valat JP. Incidence of osteoperiostitis of the great toe in psoriatic arthritis. J Rheumatol 1996;23:1553-6.
42. Boisseau-Garsaud AM, Beylot-Barry M, Doutre MS, Beylot C, Baran R. Psoriatic onycho-pachydermo-periostitis: a variant of psoriatic distal interphalangeal arthritis? Arch Dermatol 1996;132: 176-80.
43. Carr AJ, Cole WG, Roberton DM, Chow CW. Chronic multifocal osteomyelitis. J Bone Joint Surg Br 1993;75:582-91.
44. Zanolli MD, Wikle JS. Joint complaints in psoriasis patients. Int J Dermatol 1992;31:488-91.
45. Stern RS. The epidemiology of joint complaints in patients with psoriasis. J Rheumatol 1985;12:315-20.
46. McGonagle D, Gibbon W, Emery P. Classification of arthritis based on enthesitis. Lancet 1998;352:1137-40.
47. Keffer J, Probert L, Cazlaris H, Georgopoulos S, Kaslaris E, Kioussis D, et al. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J 1991;10:4025-31.
48. Gladman DD. Psoriatic arthritis. In: Khan MA, editor. Spine: state of the art reviews. Ankylosing spondylitis and related spondyloarthropathies. Philadelphia: Hanley and Belfus; 1990. p. 637-56.
49. Märker-Hermann E, Fassbender H-G, Kessler S, Thomssen H, Meyer zum Büschenfelde K-H, Blessing M. Transgenic mice with an epidermal overexpression of bone morphogenic protein-6 (BMP-6) present with psoriatic skin lesions and osteoarthropathy [abstract]. Arthritis Rheum 1997;40 Suppl 9:S261.
50. Buskila D, Langevitz P, Gladman DD, Urowitz S, Smythe HA. Patients with rheumatoid arthritis are more tender than those with psoriatic arthritis. J Rheumatol 1992;19:1115-9.
51. Espinoza LR, Vasey FB, Espinoza CG, Bocanegra TS, Germain BF. Vascular changes in psoriatic synovium: a light and electron microscopic study. Arthritis Rheum 1982;25:677-84.
52. Veale D, Yanni G, Rogers S, Barnes L, Bresnihan B, FitzGerald O. Reduced synovial membrane macrophage numbers, ELAM-1 expression, and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis. Arthritis Rheum 1993;36: 893-900.
53. Jones SM, Dixey J, Hall ND, McHugh NJ. Expression of the cutaneous lymphocyte antigen and its counter-receptor E-selectin in the skin and joints of patients with psoriatic arthritis. Br J Rheumatol 1997;36:748-57.
54. Hammer RE, Maika SD, Richardson JA, Tang JP, Taurog JD. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders. Cell 1990;63:1099-112.
55. Blessing M, Schirmacher P, Kaiser S. Overexpression of bone morphogenetic protein-6 (BMP-6) in the epidermis of transgenic mice: inhibition or stimulation of proliferation depending on the pattern of transgene expression and formation of psoriatic lesions. J Cell Biol 1996;135:227-39.
56. Jones SM, Armas JB, Cohen MG, Lovell CR, Evison G, McHugh NJ. Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease. Br J Rheumatol 1994;33: 834-9.
57. Lee RT, Briggs WH, Cheng GC, Rossiter HB, Libby P, Kupper T. Mechanical deformation promotes secretion of IL-1 alpha and IL-1 receptor antagonist. J Immunol 1997;159:5084-8.
58. Carroll JM, Romero MR, Watt FM. Suprabasal integrin expression in the epidermis of transgenic mice results in developmental defects and a phenotype resembling psoriasis. Cell 1995;83:957-68.
59. Schon MP, Detmar M, Parker CM. Murine psoriasis-like disorder induced by naive CD4+ T cells. Nat Med 1997;3:183-8.
60. Gottlieb SL, Gilleaudeau P, Johnson R, Estes L, Woodworth TG, Gottlieb AB, et al. Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nat Med 1995;1:442-7.
61. Wrone-Smith T, Nickoloff BJ. Dermal injection of immunocytes induces psoriasis. J Clin Invest 1996;98:1878-87.
62. Goodfield M. Skin lesions in psoriasis. Baillieres Clin Rheumatol 1994;8:295-316.